205 related articles for article (PubMed ID: 11329012)
41. Optimized approach for the identification of highly efficient correctors of nonsense mutations in human diseases.
Benhabiles H; Gonzalez-Hilarion S; Amand S; Bailly C; Prévotat A; Reix P; Hubert D; Adriaenssens E; Rebuffat S; Tulasne D; Lejeune F
PLoS One; 2017; 12(11):e0187930. PubMed ID: 29131862
[TBL] [Abstract][Full Text] [Related]
42. Identification and selective degradation of neopeptide-containing truncated mutant proteins in the tumors with high microsatellite instability.
Kim WK; Park M; Park M; Kim YJ; Shin N; Kim HK; You KT; Kim H
Clin Cancer Res; 2013 Jul; 19(13):3369-82. PubMed ID: 23674496
[TBL] [Abstract][Full Text] [Related]
43. Nonsense-mediated decay in genetic disease: friend or foe?
Miller JN; Pearce DA
Mutat Res Rev Mutat Res; 2014; 762():52-64. PubMed ID: 25485595
[TBL] [Abstract][Full Text] [Related]
44. Alternative splicing of MLH1 messenger RNA in human normal cells.
Charbonnier F; Martin C; Scotte M; Sibert L; Moreau V; Frebourg T
Cancer Res; 1995 May; 55(9):1839-41. PubMed ID: 7728749
[TBL] [Abstract][Full Text] [Related]
45. Two nonsense mutations cause protein C deficiency by nonsense-mediated mRNA decay.
Luan CJ; Shen W; Yu Z; Chen L; Gu Y; Tang LY; Wang ZG; Dai L; Gu MM
Thromb Res; 2015 Apr; 135(4):733-8. PubMed ID: 25648792
[TBL] [Abstract][Full Text] [Related]
46. Nonsense-mediated mRNA decay mutation in Aspergillus nidulans.
Morozov IY; Negrete-Urtasun S; Tilburn J; Jansen CA; Caddick MX; Arst HN
Eukaryot Cell; 2006 Nov; 5(11):1838-46. PubMed ID: 16963627
[TBL] [Abstract][Full Text] [Related]
47. T-cell receptor sequences that elicit strong down-regulation of premature termination codon-bearing transcripts.
Gudikote JP; Wilkinson MF
EMBO J; 2002 Jan; 21(1-2):125-34. PubMed ID: 11782432
[TBL] [Abstract][Full Text] [Related]
48. [Mutations in the Sup35 gene impairs degradation of mRNA containing premature stop codons].
Shabel'skaia SV; Zhuravleva GA
Mol Biol (Mosk); 2010; 44(1):51-9. PubMed ID: 20198859
[TBL] [Abstract][Full Text] [Related]
49. A 3' UTR sequence stabilizes termination codons in the unspliced RNA of Rous sarcoma virus.
Weil JE; Beemon KL
RNA; 2006 Jan; 12(1):102-10. PubMed ID: 16301601
[TBL] [Abstract][Full Text] [Related]
50. Optimization of experimental conditions for RNA-based sequencing of MLH1 and MSH2 genes.
Jakubowska A; Górski B; Kurzawski G; Debniak T; Hadaczek P; Cybulski C; Kladny J; Oszurek O; Scott RJ; Lubinski J
Hum Mutat; 2001; 17(1):52-60. PubMed ID: 11139242
[TBL] [Abstract][Full Text] [Related]
51. An activated 5' cryptic splice site in the human ALG3 gene generates a premature termination codon insensitive to nonsense-mediated mRNA decay in a new case of congenital disorder of glycosylation type Id (CDG-Id).
Denecke J; Kranz C; Kemming D; Koch HG; Marquardt T
Hum Mutat; 2004 May; 23(5):477-86. PubMed ID: 15108280
[TBL] [Abstract][Full Text] [Related]
52. A novel therapeutic approach for genetic diseases by introduction of suppressor tRNA.
Sako Y; Usuki F; Suga H
Nucleic Acids Symp Ser (Oxf); 2006; (50):239-40. PubMed ID: 17150906
[TBL] [Abstract][Full Text] [Related]
53. A minor alternative transcript of the fumarylacetoacetate hydrolase gene produces a protein despite being likely subjected to nonsense-mediated mRNA decay.
Dreumont N; Maresca A; Boisclair-Lachance JF; Bergeron A; Tanguay RM
BMC Mol Biol; 2005 Jan; 6():1. PubMed ID: 15638932
[TBL] [Abstract][Full Text] [Related]
54. The upstream open reading frame of the Arabidopsis AtMHX gene has a strong impact on transcript accumulation through the nonsense-mediated mRNA decay pathway.
Saul H; Elharrar E; Gaash R; Eliaz D; Valenci M; Akua T; Avramov M; Frankel N; Berezin I; Gottlieb D; Elazar M; David-Assael O; Tcherkas V; Mizrachi K; Shaul O
Plant J; 2009 Dec; 60(6):1031-42. PubMed ID: 19754518
[TBL] [Abstract][Full Text] [Related]
55. [Nonsense-mediated mRNA decay (NMD)--on guard of mRNA quality].
Dzikiewicz A; Szweykowska-Kulińska Z
Postepy Biochem; 2006; 52(4):390-8. PubMed ID: 17536508
[TBL] [Abstract][Full Text] [Related]
56. Inhibition of nonsense-mediated messenger RNA decay in clinical samples facilitates detection of human MSH2 mutations with an in vivo fusion protein assay and conventional techniques.
Andreutti-Zaugg C; Scott RJ; Iggo R
Cancer Res; 1997 Aug; 57(15):3288-93. PubMed ID: 9242462
[TBL] [Abstract][Full Text] [Related]
57. Nonsense mutation-dependent reinitiation of translation in mammalian cells.
Cohen S; Kramarski L; Levi S; Deshe N; Ben David O; Arbely E
Nucleic Acids Res; 2019 Jul; 47(12):6330-6338. PubMed ID: 31045216
[TBL] [Abstract][Full Text] [Related]
58. Ten novel MSH2 and MLH1 germline mutations in families with HNPCC.
Krüger S; Bier A; Plaschke J; Höhl R; Aust DE; Kreuz FR; Pistorius SR; Saeger HD; Rothhammer V; Al-Taie O; Schackert HK
Hum Mutat; 2004 Oct; 24(4):351-2. PubMed ID: 15365996
[TBL] [Abstract][Full Text] [Related]
59. Identifying Genes Whose Mutant Transcripts Cause Dominant Disease Traits by Potential Gain-of-Function Alleles.
Coban-Akdemir Z; White JJ; Song X; Jhangiani SN; Fatih JM; Gambin T; Bayram Y; Chinn IK; Karaca E; Punetha J; Poli C; ; Boerwinkle E; Shaw CA; Orange JS; Gibbs RA; Lappalainen T; Lupski JR; Carvalho CMB
Am J Hum Genet; 2018 Aug; 103(2):171-187. PubMed ID: 30032986
[TBL] [Abstract][Full Text] [Related]
60. A flow cytometry-based reporter assay identifies macrolide antibiotics as nonsense mutation read-through agents.
Caspi M; Firsow A; Rajkumar R; Skalka N; Moshkovitz I; Munitz A; Pasmanik-Chor M; Greif H; Megido D; Kariv R; Rosenberg DW; Rosin-Arbesfeld R
J Mol Med (Berl); 2016 Apr; 94(4):469-82. PubMed ID: 26620677
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
